TXK
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
TXK tyrosine kinase | MIM:600058 | Ensembl:ENSG00000074966 | HGNC:HGNC:12434 | PA37090 | 4p12 |
GO terms in TXK
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | ISS | GO:0001816 | cytokine production |
BP | IBA | GO:0002250 | adaptive immune response |
BP | ISS | GO:0002250 | adaptive immune response |
BP | IDA | GO:0006357 | regulation of transcription by RNA polymerase II |
BP | IEA | GO:0006366 | transcription by RNA polymerase II |
BP | IDA | GO:0006468 | protein phosphorylation |
BP | IBA | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway |
BP | ISS | GO:0007202 | activation of phospholipase C activity |
BP | IBA | GO:0030154 | cell differentiation |
BP | IBA | GO:0030217 | T cell differentiation |
BP | IDA | GO:0032729 | positive regulation of interferon-gamma production |
BP | IBA | GO:0038083 | peptidyl-tyrosine autophosphorylation |
BP | IBA | GO:0042127 | regulation of cell proliferation |
BP | IBA | GO:0045087 | innate immune response |
BP | IDA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | IDA | GO:0046777 | protein autophosphorylation |
BP | IBA | GO:0050852 | T cell receptor signaling pathway |
BP | ISS | GO:0050852 | T cell receptor signaling pathway |
BP | IBA | GO:0050853 | B cell receptor signaling pathway |
BP | IDA | GO:0060335 | positive regulation of interferon-gamma-mediated signaling pathway |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005737 | cytoplasm |
CC | IBA | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane |
MF | IDA | GO:0000978 | RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | IDA | GO:0001012 | RNA polymerase II regulatory region DNA binding |
MF | IDA | GO:0001077 | transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | IBA | GO:0004715 | non-membrane spanning protein tyrosine kinase activity |
MF | IBA | GO:0005102 | signaling receptor binding |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
Gene expression in normal tissue: TXK
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in TXK
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-168249 | Innate Immune System |
reactome | R-HSA-168249 | Innate Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling |
reactome | R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling |
reactome | R-HSA-2871809 | FCERI mediated Ca+2 mobilization |
reactome | R-HSA-2871809 | FCERI mediated Ca+2 mobilization |
netpath | Pathway_TCR | TCR |
kegg | hsa04670 | Leukocyte transendothelial migration - Homo sapiens (human) |
wikipathways | WP306 | Focal Adhesion |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD872 | BRD7137 | 4 |
iGMDRD414 | MST-312 | 2 |
iGMDRD329 | Merck60 | 4 |
iGMDRD322 | FK 866 | 2 |
iGMDRD158 | NSC141540 | 5 |
iGMDRD137 | Indisulam | 1 |
iGMDRD705 | Nakiterpiosin | 1 |
iGMDRD231 | Importazole | 3 |
iGMDRD341 | Triacsin c | 2 |
iGMDRD314 | Tanespimycin | 3 |
iGMDRD177 | Teniposide | 2 |
iGMDRD154 | NSC23766 | 4 |
iGMDRD307 | Manumycin A | 3 |
iGMDRD512 | nutlin 3 | 2 |
iGMDRD560 | MK-2206 | 3 |
iGMDRD405 | PIK-75 | 4 |
iGMDRD399 | Selumetinib | 2 |
iGMDRD74 | Idarubicin | 3 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD640 | CAY10618 | 3 |
iGMDRD690 | PRIMA-1MET | 3 |
iGMDRD451 | Serdemetan | 2 |
iGMDRD255 | SB225002 | 3 |
iGMDRD294 | Batimastat | 2 |
iGMDRD187 | BRD9876 | 2 |
iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 2 |
iGMDRD61 | Kinetin riboside | 3 |
iGMDRD679 | Bistramide A | 1 |
iGMDRD297 | Austocystin D | 2 |
iGMDRD375 | GW-405833 | 2 |
iGMDRD1008 | SR-II-138A | 1 |
iGMDRD229 | B02 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in TXK